Arbor Pharmaceuticals
A pharmaceutical company developing treatment products for the cardiovascular and neurological conditions
1
Funding Rounds
$34.8m
Money raised
Funding series
Funding Series Analysis
The company Arbor Pharmaceuticals has raised a total of $34.8m in funding over 1 rounds.
Key Insights:
- Arbor Pharmaceuticals Series B round: $34.8m
Arbor Pharmaceuticals Series B round
$34.8m
Industries
Arbor Pharmaceuticals is active in the following industries: